flash-tech

12 Months From Now, Will You Wish You Bought SpaceX Today?

AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report.

SpaceX is expected to secure index entry in the coming days and weeks, unlocking a new source of investor demand after there’s been “striking” breadth so far.

Jumper isn't the only big name leaving Google DeepMind.

MDA Space to buy RTX-owned Blue Canyon Technologies for $620M

While it's not flashy like Apple’s new Siri AI and Apple Intelligence upgrades, there are still a number of additions to iOS 27 worth looking at.

Forget SpaceX: See This Overlooked AI Stock in Donald Trump’s Portfolio

In Lubra, Nepal’s last Bon village, climate-driven floods are destroying homes and land, endangering ancient traditions.

Notable tech headlines for the week: Accenture, Nvidia, Micron in focus

The capital influx from the SpaceX IPO, which ended its first week of trading up 37% from its IPO price, highlights strong investor enthusiasm. Bloomberg Radio host of "Masters in Business" Barry Ritholtz comes on Bloomberg This Weekend to discuss the potential impact of this enthusiasm on the upcom